IDEAYA Biosciences, Inc. (IDYA) stock
IDYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/307% below fair value
$27.40−2.96 (-9.75%)
Close on Nov 17, 2026Market cap $2.64BP/E –Yield –
IDEAYA Biosciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
IDEAYA Biosciences's price to sales ratio was 13.5× on Nov 11, 2026, against 251.3× a year earlier. Over the last 4 years it ranged from 11.7× to 254.2×, with a median of 23.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 13.5× | −235.3 |
| 2025 | Apr 30, 2025 | 248.8× | +69.7 |
| 2024 | Oct 31, 2024 | 179.1× | +90.3 |
| 2023 | Dec 29, 2023 | 88.8× | +71.3 |
| 2022 | Dec 30, 2022 | 17.5× | −8.1 |
| 2021 | Dec 31, 2021 | 25.6× | – |
See a number that looks wrong?